콘텐츠로 건너뛰기
Merck
  • Sensitization to triglycidylisocyanurate (TGIC) with cutaneous and respiratory manifestations.

Sensitization to triglycidylisocyanurate (TGIC) with cutaneous and respiratory manifestations.

Allergy (1999-08-12)
L Meuleman, A Goossens, C Linders, F Rochette, B Nemery
초록

The case is presented of a man with allergic contact dermatitis and occupational asthma due to triglycidylisocyanurate (TGIC), which is used as a hardener in thermosetting powder paint. The contact dermatitis was confirmed by patch testing (TGIC 0.5% and 5% in petrolatum), and the occupational asthma was confirmed by bronchial provocation testing: two challenges to an aerosol of lactose containing TGIC (0.05% and 0.1%, w/w, each for 0.5+1+2+4 min) led to a maximal decrease in FEV1 of 22% and 31% after 6 and 4 h, respectively. Skin prick tests with unconjugated TGIC were possibly positive. This case confirms that exposure to TGIC in powder paints may cause not only contact dermatitis, but also occupational asthma.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Tris(2,3-epoxypropyl) isocyanurate